Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
25 studies found for:    " May 06, 2009":" June 05, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Conditions: HIV Infection;   HIV;   Acquired Immunodeficiency Syndrome
Interventions: Drug: etravirine (ETR, TMC125);   Drug: efavirenz (EFV)
2 Completed
Has Results
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Atazanavir (ATV) 300 mg;   Drug: Atazanavir (ATV) 400 mg;   Drug: Ritonavir (rtv) 100 mg;   Drug: Nucleo(side)/(tide) reverse transcriptase inhibitors (NRTIs);   Drug: Etravirine (ETR) 200 mg;   Drug: Tenofovir disoproxil fumarate (TDF) 300 mg
3 Unknown  Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
Conditions: HIV Infections;   Human Immunodeficiency Virus;   Malaria;   Plasmodium Falciparum;   Diarrhea
Intervention: Other: Bednets and Water Purification
4 Recruiting Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV
Conditions: HIV;   Acquired Immunodeficiency Syndrome;   Cardiovascular Diseases
Interventions: Behavioral: Exercise Program;   Behavioral: Control Group
5 Unknown  Exercise for Patients With HIV Infections
Conditions: HIV Infections;   Lipodystrophy;   Inflammation
Intervention: Behavioral: Exercise
6 Completed Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment
Conditions: Human Immunodeficiency Virus;   Chronic Hepatitis C
Interventions: Drug: pegylated interferon-alpha (Pegasys);   Drug: ribavirin (COPEGUS)
7 Unknown  Raltegravir in the Swiss HIV Cohort Study
Condition: HIV Infection
Intervention: Drug: Raltegravir
8 Completed Early Immune Responses to Vaccination - A Substudy to HVTN 205
Condition: HIV Infections
Interventions: Biological: JS7 DNA vaccine;   Biological: MVA/HIV62 vaccine
9 Completed TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP)
Condition: HIV Infections
Intervention: Drug: TMC207; nevirapine
10 Unknown  Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
Conditions: Hypercholesterolemia;   HIV Infections
Interventions: Drug: Ezetimibe;   Drug: Rosuvastatin (standard care)
11 Completed Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine
Condition: HIV Infections
Interventions: Biological: ADVAX;   Biological: TBC-M4;   Other: Placebo
12 Completed Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
Conditions: HIV Infections;   COPD
Intervention:
13 Active, not recruiting New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
Condition: HIV Infections
Intervention: Drug: 2 NRTI + 1 PI/r + Maraviroc + Raltegravir
14 Active, not recruiting HIV and Kidney Function Study
Conditions: HIV Infections;   AIDS
Intervention:
15 Completed Vitamin D Supplementation and CD4 Count in HIV-Infected Children
Condition: HIV
Interventions: Dietary Supplement: Vitamin D;   Drug: No supplementation
16 Completed
Has Results
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
Condition: HIV-1 Infection
Interventions: Drug: darunavir;   Drug: ritonavir;   Drug: zidovudine;   Drug: lamivudine;   Drug: abacavir
17 Withdrawn Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Condition: HIV-1 Infections
Interventions: Drug: TDF/FTC Once-Daily + Raltegravir 400 mg Orally Twice-Daily;   Drug: TDF/FTC + Efavirenz (Atripla) Once-Daily
18 Unknown  Examining Hair to Determine Tenofovir Exposure
Condition: HIV
Intervention: Drug: Tenofovir Disoproxil Fumarate
19 Completed Glutathione and Its Precursors in HIV-Infected Patients
Condition: HIV Infection
Intervention: Dietary Supplement: Glutathione precursors
20 Completed A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Conditions: Postherpetic Neuralgia;   Diabetic Neuropathy;   Complex Regional Pain Syndrome;   Carpal Tunnel Syndrome;   HIV Neuropathy;   Idiopathic Sensory Neuropathy;   Peripheral Neuropathy
Interventions: Drug: Placebo Capsules + Placebo Patch;   Drug: Placebo capsules + Lidoderm®;   Drug: Gabapentin + Placebo;   Drug: Gabapentin + Lidoderm®;   Drug: Gabapentin 300 mg capsules 1800 mg/day + placebo patch;   Drug: Gabapentin 1800 mg/day + Lidoderm patch

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years